{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:43:53Z","timestamp":1793256233496,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.urolonc.2019.09.001","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:26:16Z","timestamp":1571185576000},"page":"225-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Prospective multicentre study using high intensity focused ultrasound (HIFU) for the focal treatment of prostate cancer: Safety outcomes and complications"],"prefix":"10.1016","volume":"38","author":[{"given":"F.A.","family":"Schmid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Schindele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mortezavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Spitznagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Sulser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8717-2096","authenticated-orcid":false,"given":"M.","family":"Schostak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Eberli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.urolonc.2019.09.001_bib0001","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMcibr0905562","article-title":"The index lesion and the origin of prostate cancer","volume":"361","author":"Ahmed","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2019.09.001_bib0002","doi-asserted-by":"crossref","first-page":"k3519","DOI":"10.1136\/bmj.k3519","article-title":"Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis","volume":"362","author":"Ilic","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.urolonc.2019.09.001_bib0003","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.eururo.2017.07.018","article-title":"Active surveillance versus watchful waiting for localized prostate cancer: a model to inform decisions","volume":"72","author":"Loeb","year":"2017","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.urolonc.2019.09.001_bib0004","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1464-410X.2012.11262.x","article-title":"High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer","volume":"110","author":"Cordeiro","year":"2012","journal-title":"BJU Int"},{"issue":"S1","key":"10.1016\/j.urolonc.2019.09.001_bib0005","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1089\/end.2016.0548","article-title":"High-intensity focused ultrasound for the treatment of prostate cancer: a review","volume":"31","author":"Chaussy","year":"2017","journal-title":"J Endourol"},{"issue":"11","key":"10.1016\/j.urolonc.2019.09.001_bib0006","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ncponc0959","article-title":"Will focal therapy become a standard of care for men with localized prostate cancer?","volume":"4","author":"Ahmed","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.urolonc.2019.09.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1111\/bju.14710","article-title":"Medium term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using HIFU for primary localized prostate cancer","author":"Stabile","year":"2019","journal-title":"BJU Int"},{"issue":"12","key":"10.1016\/j.urolonc.2019.09.001_bib0008","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.urolonc.2019.09.001_bib0009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.juro.2016.07.080","article-title":"Clinical use of expanded prostate cancer index composite for clinical practice to assess patient reported prostate cancer quality of life following robot-assisted radical prostatectomy","volume":"197","author":"Wagner","year":"2017","journal-title":"J Urol"},{"issue":"15","key":"10.1016\/j.urolonc.2019.09.001_bib0010","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.urolonc.2019.09.001_bib0011","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2012.11.057","article-title":"Morbidity of focal therapy in the treatment of localized prostate cancer","volume":"63","author":"Barret","year":"2013","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2019.09.001_bib0012","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.juro.2017.03.137","article-title":"Partial gland treatment of prostate cancer using high-intensity focused ultrasound in the primary and salvage settings: a systematic review","volume":"198","author":"Golan","year":"2017","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2019.09.001_bib0013","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.semradonc.2016.08.007","article-title":"Options for salvage of radiation failures for prostate cancer","volume":"27","author":"Tetreault-Laflamme","year":"2017","journal-title":"Semin Radiat Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2019.09.001_bib0014","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/end.2018.0468","article-title":"Non-whole-gland high-intensity focused ultrasound vs whole-gland high-intensity focused ultrasound for management of localized prostate cancer: 1-year oncological and functional outcomes","volume":"33","author":"Lei","year":"2019","journal-title":"J Endourol"},{"issue":"2","key":"10.1016\/j.urolonc.2019.09.001_bib0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.eururo.2016.09.039","article-title":"Focal high intensity focused ultrasound of unilateral localized prostate cancer: a prospective multicentric hemiablation study of 111 patients","volume":"71","author":"Rischmann","year":"2017","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.urolonc.2019.09.001_bib0016","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/iju.12876","article-title":"Urethra-sparing high-intensity focused ultrasound for localized prostate cancer: functional and oncological outcomes","volume":"22","author":"Shoji","year":"2015","journal-title":"Int J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2019.09.001_bib0017","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.juro.2017.06.078","article-title":"High intensity focused ultrasound for radiorecurrent prostate cancer: a north American clinical trial","volume":"199","author":"Jones","year":"2018","journal-title":"J Urol"},{"issue":"7","key":"10.1016\/j.urolonc.2019.09.001_bib0018","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/end.2018.0809","article-title":"Comprehensive evaluation of focal therapy complications in prostate cancer: a standardised methodology","volume":"33","author":"Bakavicius","year":"2019","journal-title":"J Endourol"},{"issue":"2","key":"10.1016\/j.urolonc.2019.09.001_bib0019","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41391-018-0042-0","article-title":"Which technology to select for primary focal treatment of prostate cancer?-European Section of Urotechnology (ESUT) position statement","volume":"21","author":"Ganzer","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.urolonc.2019.09.001_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eururo.2016.08.044","article-title":"New and established technology in focal ablation of the prostate: a systematic review","volume":"71","author":"Valerio","year":"2017","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2019.09.001_bib0021","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.eururo.2014.09.018","article-title":"Focal therapy: patients, interventions, and outcomes\u2013a report from a consensus meeting","volume":"67","author":"Donaldson","year":"2015","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2019.09.001_bib0022","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MOU.0000000000000045","article-title":"How to select the right patients for focal therapy of prostate cancer?","volume":"24","author":"Passoni","year":"2014","journal-title":"Curr Opin Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2019.09.001_bib0023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.juro.2014.07.098","article-title":"Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance","volume":"193","author":"Radtke","year":"2015","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2019.09.001_bib0024","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.eururo.2007.10.062","article-title":"First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer","volume":"53","author":"Blana","year":"2008","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2019.09.001_bib0025","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1470-2045(12)70121-3","article-title":"Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study","volume":"13","author":"Ahmed","year":"2012","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2019.09.001_bib0026","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/end.2016.0702","article-title":"Comparing high-intensity focal ultrasound hemiablation to robotic radical prostatectomy in the management of unilateral prostate cancer: a matched-pair analysis","volume":"31","author":"Albisinni","year":"2017","journal-title":"J Endourol"},{"issue":"1","key":"10.1016\/j.urolonc.2019.09.001_bib0027","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.juro.2017.08.076","article-title":"Comparative analysis of partial gland ablation and radical prostatectomy to treat low and intermediate risk prostate cancer: oncologic and functional outcomes","volume":"199","author":"Garcia-Barreras","year":"2018","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2019.09.001_bib0028","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.eururo.2013.04.039","article-title":"Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients","volume":"65","author":"Crouzet","year":"2014","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2019.09.001_bib0029","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.eururo.2016.02.054","article-title":"Medium-term outcomes after whole-gland high-intensity focused ultrasound for the treatment of nonmetastatic prostate cancer from a multicentre registry cohort","volume":"70","author":"Dickinson","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2019.09.001_bib0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.eururo.2015.06.018","article-title":"Focal high-intensity focused ultrasound targeted hemiablation for unilateral prostate cancer: a prospective evaluation of oncologic and functional outcomes","volume":"69","author":"Feijoo","year":"2016","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2019.09.001_bib0031","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.juro.2018.07.040","article-title":"Oncologic and functional outcome of partial gland ablation with HIFU for localized prostate cancer","volume":"201","author":"Bass","year":"2019","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919303527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919303527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:18:15Z","timestamp":1761041895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143919303527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1078143919303527"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.09.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective multicentre study using high intensity focused ultrasound (HIFU) for the focal treatment of prostate cancer: Safety outcomes and complications","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}